Eurofins Infinity Laboratory Group Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 2200 W 97th Place, Crown Point, Indiana (IN) 46307-2344, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 3008580332 · DUNS 118120524
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2026-03-05
- NAIDrug Quality Assurance2018-11-27
- NAIDrug Quality Assurance2014-04-04
Drugs this plant is listed as making
1 distinct drugs across 4 products name this site in their FDA label.
- buprenorphine hydrochloride, naloxone hydrochlorideIndivior Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.